Dra. Lucía Díaz graduated in Chemistry from the University of Salamanca in 2005 with first class honours. After one year as postgraduate fellow at ChemOvation company in Horsham (UK), working on the synthesis of new drugs for big pharmaceutical companies, she received a grant to join the Research Unit on BioActive Molecules (RUBAM) at CSIC in Barcelona, where she obtained her PhD in Medicinal Chemistry in 2011.

She gained experience in organic chemistry, cell biology and computational chemistry, and performed predoctoral stays at the University of Uppsala(Sweden) and the University of Santiago de Compostela. She has co-authored several publications in peer-reviewed journals and is co-inventor of 2 international patent applications.

After one year of postdoctoral training in the Medicinal Chemistry group at CSIC, she joined the Life Sciences Department in Barcelona Supercomputing Center, where she focused on the discovery of potential drugs for the treatment of human gliomas by means of molecular modeling techniques. She is currently working at Nostrum Biodiscovery as Chief Business Development Officer and Drug Discovery projects coordinator.